Physician profile
Ariel Ramirez
NPI 1053988956
$1,567.15
in general payments reported to CMS, 2019-2025
14 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $282 · 2023: $609 · 2024: $370 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $486.95 | 2022-2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Closurefast |
| Novartis Pharmaceuticals Corporation | $207.15 | 2022-2025 | |
| Boston Scientific Corporation | $177.52 | 2023 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $158.94 | 2022-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $106.70 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.68 | 2024 | Lifevest |
| Abbott Laboratories | $92.31 | 2022 | |
| Merck Sharp & Dohme LLC | $65.61 | 2022-2024 | Verquvo |
| Impulse Dynamics (USA) INC. | $54.72 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $38.27 | 2024 | |
| Atricure, INC. | $28.18 | 2023 | |
| Scpharmaceuticals INC. | $24.80 | 2025 | |
| Inspire Medical Systems, INC. | $23.32 | 2025 | Inspire |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.